Cascadia Drug Development Group

The Cascadia Drug Development Group was founded by seasoned industry experts who are passionate about immunology and drug development. CDDG provides strategic advisory support, including indication prioritization and investment opportunity diligence, as well as planning and tactical oversight of therapeutic development activities. Importantly, we help integrate quality decisions into programs early and focus on efficiently bridging the gap between discovery, lead generation and initial clinical proof of concept. By offering a flexible and virtual structure and leveraging an externalized research model, we easily adapt to client and project needs to reduce overall costs. Our aspiration is to provide the highest quality approach to drug development that maximizes the value of excellent therapeutic opportunities around the globe.